The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Result of AGM

16 May 2019 14:04

RNS Number : 3037Z
Spire Healthcare Group PLC
16 May 2019
 

SPIRE HEALTHCARE GROUP PLC (the 'Company') 16 May 2019

 

Results of 2019 Annual General Meeting

 

At the fifth annual general meeting of the Company held at 11.00am today at 65 Fleet Street, London EC4Y 1HS, all resolutions were passed on a poll. The polling results for each resolution are set out below:

 

 

RESOLUTION

VOTES

FOR

%

VOTES

AGAINST

%

% of ISC VOTED

VOTES

WITHHELD

1

Receive and adopt the 2018 Annual Report and Accounts

318,462,320

100.00

238

0.00

79.40%

130,736

2

Approve the 2018 Directors' Remuneration Report

317,441,595

99.83

535,308

0.17

79.28%

616,391

3

Approve the 2018 Final Dividend

318,590,936

100.00

238

0.00

79.43%

2,120

4

Re-elect Adèle Anderson

318,086,149

99.84

497,352

0.16

79.43%

9,793

5

Re-elect Justin Ash

313,911,827

98.53

4,671,674

1.47

79.43%

9,793

6

Re-elect Tony Bourne

318,214,919

99.88

368,582

0.12

79.43%

9,793

7

Re-elect Dame Janet Husband

310,338,708

97.41

8,244,793

2.59

79.43%

9,793

8

Re-elect Simon Rowlands

313,812,006

98.50

4,771,495

1.50

79.43%

9,793

9

Re-elect Garry Watts

304,682,092

95.64

13,901,409

4.36

79.43%

9,793

10

Elect Martin Angle

318,362,533

99.93

220,968

0.07

79.43%

9,793

11

Elect Jitesh Sodha

313,801,659

98.50

4,781,842

1.50

79.43%

9,793

12

Elect Dr Ronnie van der Merwe

313,812,141

98.50

4,771,915

1.50

79.43%

9,238

13

Reappointment of Ernst & Young LLP as auditors

317,959,875

99.80

621,944

0.20

79.43%

11,475

14

Authorise the Directors' to determine the auditor's remuneration

318,582,644

100.00

6,275

0.00

79.43%

4,375

15

Authorise political expenditure

311,859,242

97.89

6,727,464

2.11

79.43%

6,588

16

Renew the authority to allot shares

317,607,423

99.69

983,871

0.31

79.43%

2,000

17

Renew the authority to disapply statutory pre-emption rights*

318,238,250

99.89

353,044

0.11

79.43%

2,000

18

Renew the authority to disapply statutory pre-emption rights for an acquisition or specified capital investment*

287,698,544

90.30

30,890,205

9.70

79.43%

4,545

19

Authorise the Company to purchase its own shares*

317,646,826

99.72

894,776

0.28

79.42%

51,692

20

Authorise general meetings, other than annual general meetings, to be held on 14 clear days' notice*

315,628,633

99.07

2,962,106

0.93

79.43%

2,555

 

*Special Resolution

 

A trading update was released by the Company at 7.00am this morning.

 

Notes:

i) Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.

ii) The total number of shares in issue (ISC) is 401,081,391.

iii) A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

iv) All percentages are shown to two decimal places.

This information will also shortly be available to view on the Company's website at: www.spirehealthcare.com.

Copies of the resolutions dealing with special business passed at the Annual General Meeting have been sent to the National Storage Mechanism and will shortly be available for inspection.

 

 

Philip Davies

Deputy Company Secretary

16 May 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGSFFFDMFUSESI

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.